Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Exact Sciences Corporation

EXK
Current price
61.15 EUR -0.77 EUR (-1.24%)
Last closed 60.23 EUR
Company
ISIN US30063P1057
Sector Healthcare
Industry Diagnostics & Research
Exchange Munich Exchange
Capitalization 11 126 926 387 EUR
Yield for 12 month -12.79 %
1Y
3Y
5Y
10Y
15Y
EXK
21.11.2021 - 28.11.2021

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. Address: 5505 Endeavor Lane, Madison, WI, United States, 53719

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

133.8 EUR

P/E ratio

Dividend Yield

Current Year

+2 246 612 197 EUR

Last Year

+1 873 201 981 EUR

Current Quarter

+628 448 835 EUR

Last Quarter

+572 961 307 EUR

Current Year

+1 658 663 686 EUR

Last Year

+1 356 977 436 EUR

Current Quarter

+457 870 071 EUR

Last Quarter

+420 087 504 EUR

Key Figures EXK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -68 890 039 EUR
Operating Margin TTM -3.13 %
PE Ratio
Return On Assets TTM -2.71 %
PEG Ratio
Return On Equity TTM -5.6 %
Wall Street Target Price 133.8 EUR
Revenue TTM 2 611 595 468 EUR
Book Value 17.28 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 12.4 %
Dividend Yield
Gross Profit TTM 1 509 644 795 EUR
Earnings per share -0.86 EUR
Diluted Eps TTM -0.86 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -6.7 %

Dividend Analytics EXK

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History EXK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation EXK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 2500
Enterprise Value Revenue 5.331
Price Sales TTM 4.2606
Enterprise Value EBITDA 201.0028
Price Book MRQ 3.8618

Financials EXK

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators EXK

For 52 weeks

38.35 EUR 70.6 EUR
50 Day MA 49.4 EUR
Shares Short Prior Month
200 Day MA 53.53 EUR
Short Ratio
Shares Short
Short Percent